Article Text


1331 Percutaneous Transhepatic Ultrasound-Guided Cardiac Catheterization in a Fetal Lamb Model
  1. A Edwards1,2,
  2. S Menahem3,
  3. I Nitsos1,
  4. Y Chan4,
  5. A Veldman1,
  6. D Schranz5,
  7. F Wong1
  1. 1The Ritchie Centre, Monash University
  2. 2Perinatal Services
  3. 3Fetal Cardiac Unit
  4. 4Department of Pathology, Monash Medical Centre, Melbourne, VIC, Australia
  5. 5Department of Paediatric Cardiology, Justus Liebig University, Giessen, Germany


Background Fetal cardiac intervention may alter the progression of cardiac conditions. Fetal heart access by direct puncture of the fetal heart under ultrasound guidance has been established, but with considerable technical difficulties. We aim to investigate the feasibility of fetal cardiac access using a percutaneous transhepatic approach in the mid-gestational fetal lamb, as a model for human fetus.

Method Eight fetal lambs of 95–97 days gestation (term 147 days) were studied. Under ultrasound guidance, the fetal right hepatic vein was punctured percutaneously, using a 16GA intravenous cannula (BD Angiocath). A coronary catheter (FineCrossTM MG, Terumo) was inserted into the 16 GA cannula, over a 0.014inch guidewire, and advanced into the inferior vena cava and the right atrium. Contrast was injected to document position of the catheter. Three fetal lambs were to be euthanized at the end of the procedure to evaluate blood loss. The rest were to deliver vaginally at term, and euthanized for postmortem examination.

Results Percutaneous fetal cardiac access was successful in 7 out of the 8 fetuses. All 4 heart chambers were catheterized in the last 3 fetuses. One fetus died during the procedure, post-mortem showed pericardial and peritoneal haemorrhage. The other two fetuses dedicated for immediate post-mortem, after having survived the procedure, had small haemoperitoneum. Averaged fetal weight was 1027±153g. All other lambs were born normally at term.

Conclusion Ultrasound-guided fetal cardiac catheterization through a percutaneous transhepatic approach is feasible. Our experience provides a potentially safer route for human fetal cardiac intervention at midgestational age.

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.